Hypoprothrombinemia

Hypoprothrombinemia is the indication for 1 drug in DrugBank. It is covered by 13 curated, structured indications.

Also known as: Hypoprothrombinemias · Hypoprothrombinaemia · hypopro-thrombinemia
Classified under: Cardiovascular Diseases
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hemic and Lymphatic Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Phylloquinone

Resolves to

Vocabularies

MeSHM0010925ICD-10D68.2SNOMED CT191283001MedDRA10021085UMLSC1534444

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

13Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

11Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hypoprothrombinemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.